lobbying_activities: 2862354

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2862354	6bb8fa1d-9ced-4705-bf9b-b3b6b6e7ad04	Q3	SQUIRE PATTON BOGGS	30906	ASTRAZENECA UK LTD.	2022	third_quarter	ENV	Seeking consideration of AstraZeneca's intention to substitute zero Global Warming Potential (GWP) gases for current propellants in its metered dose inhalers.	HOUSE OF REPRESENTATIVES,SENATE	100000		0	0	2022-10-11T12:34:04-04:00